Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)

被引:10
|
作者
Ronaghy, Arash [1 ]
Streilein, Robert D. [1 ]
Hall, Russell P., III [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27710 USA
关键词
Bullous pemphigoid; Auto-antibodies: IgG subclass; Rituximab; BP180; ECTODOMAIN;
D O I
10.1016/j.jdermsci.2013.11.014
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:93 / 94
页数:2
相关论文
共 43 条
  • [41] Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
    Natynki, Antti
    Leisti, Pivi
    Tuusa, Jussi
    Varpuluoma, Outi
    Huilaja, Laura
    Izumi, Kentaro
    Herukka, Sanna-Kaisa
    Ukkola, Olavi
    Junttila, Juhani
    Kokkonen, Nina
    Tasanen, Kaisa
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
    Tukaj, Stefan
    Bieber, Katja
    Pruessmann, Wiebke
    Pruessmann, Jasper N.
    Schmidt, Enno
    Zillikens, Detlef
    Ludwig, Ralf J.
    Kasperkiewicz, Michael
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (10) : 2921 - 2926
  • [43] Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
    Stefan Tukaj
    Katja Bieber
    Wiebke Prüßmann
    Jasper N. Prüßmann
    Enno Schmidt
    Detlef Zillikens
    Ralf J. Ludwig
    Michael Kasperkiewicz
    Archives of Dermatological Research, 2023, 315 : 2921 - 2926